Filter
5609
Filtered Results: 5609
Text search:
drug
development
Featured
Recommendations
489
New Publications
1474
Language
Document type
No document type
3337
Studies & Reports
906
Guidelines
699
Manuals
252
Strategic & Response Plan
183
Fact sheets
82
Training Material
81
Situation Updates
22
Infographics
14
Resource Platforms
12
Brochures
10
Online Courses
7
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
315
Global
209
Kenya
177
South Africa
134
Ethiopia
131
Uganda
129
Nigeria
119
Western and Central Europe
110
Tanzania
106
Nepal
101
Sierra Leone
92
Zambia
90
Liberia
89
Malawi
85
Africa
83
Myanmar / Burma
81
Latin America and the Carribbean
77
Ghana
75
Bangladesh
72
Rwanda
66
Namibia
61
Ukraine
57
Eastern Europe
57
Philippines
52
Asia
45
Zimbabwe
44
Cambodia
40
South–East Asia Region
40
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
27
Syria
23
Eswatini/ Swaziland
23
Senegal
22
Burkina Faso
20
Colombia
19
Germany
19
East and Southern Africa
18
Brazil
17
South Sudan
17
Cameroon
16
Haiti
15
West and Central Africa
15
USA
14
Middle East and North Africa
14
Tajikistan
13
Thailand
12
Albania
12
Venezuela
12
China
11
Vietnam
11
Pakistan
11
Guinea
10
Afghanistan
9
Eastern Europe and Central Asia
9
Georgia
9
Argentina
8
Sudan
8
Laos
7
Armenia
7
Paraguay
7
Moldova
7
Sri Lanka
7
Mexico
6
Western Pacific Region
6
North America
6
Yemen
6
North Macedonia
5
El Salvador
5
Benin
5
Peru
5
Lebanon
5
Central African Republic
5
Iraq
5
Timor Leste/ East Timor
4
Iran
4
Jordan
4
Jamaica
4
United Kingdom
4
Mali
4
Bhutan
4
Somalia
4
Madagascar
4
Turkey
3
Fiji
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Honduras
3
Angola
3
Libya
3
Switzerland
2
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Southern Africa
2
Nicaragua
2
Poland
2
Chad
2
Ecuador
2
Guatemala
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Egypt
1
Romania
1
Greece
1
Authors & Publishers
Publication Years
Category
Countries
2187
Clinical Guidelines
481
Public Health
271
Women & Child Health
216
Key Resources
159
Capacity Building
87
Pharmacy & Technologies
67
Annual Report MEDBOX
1
Toolboxes
HIV
643
Mental Health
552
TB
534
AMR
288
NTDs
247
COVID-19
209
Pharmacy
161
NCDs
120
Caregiver
110
Malaria
102
Ebola & Marburg
81
Planetary Health
78
Refugee
70
Rapid Response
65
Disability
65
Global Health Education
63
Conflict
58
Health Financing Toolbox
55
2.0 Rapid Response
28
Polio
22
Natural Hazards
20
Zika
17
Specific Hazards
16
Cholera
16
Social Ethics
15
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chikungunya fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished fr...
This video highlights the significant risks that malaria poses to pregnant and breastfeeding women in malaria-endemic regions. It follows the stories of Angavu from Kenya, Moyinoluwa from Nigeria and Lamai from Thailand. It emphasises the severe consequences that malaria can have during pregnancy, i...
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is ...
Malaria remains a significant public health concern, particularly in sub-Saharan Africa, where the majority of cases and fatalities occur, especially among children under five. Although there was a significant decline in global mortality and incidence between 2000 and 2015, progress has stalled sinc...
Combination therapy is a cornerstone of modern malaria treatment, particularly in the context of widespread multidrug resistance. Using two or more antimalarial drugs with different mechanisms simultaneously enhances efficacy, shortens treatment duration, improves compliance and delays the developme...
In the face of rapid increases in the number of hospitalizations due to COVID-19 in Latin America and the Caribbean, coupled with shortages of human and material resources, including medical equipment and gases, there is a need to redesign models of care in the Region to optimize available resources...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched. In the past few decades, deaths from NCDs in LMICs have spiked, whereas numbers in high-income countries have stabilis...
Antimicrobial resistance (AMR) and malaria remain significant public health challenges in the WHO Eastern Mediterranean Region (EMR). In 2021, the region reported 1.7 million sepsis-related deaths, with 373,000 associated with bacterial AMR. High antibiotic consumption, particularly in high-income c...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Malaria and HIV, two of the world’s most deadly diseases, are widespread, but their distribution overlaps greatly in sub-Saharan Africa. Consequently, malaria and HIV coinfection (MHC) is common in the region. In this paper, pertinent publications on the prevalence, impact, and treatment strategie...
WHO MiNDbank is an online platform bringing together country and international resources, covering mental health, substance abuse, disability, general health, human rights and development. It is part of WHO’s QualityRights campaign to end violations against people with mental disabilities. MiNDban...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac...
Perspective on drugs
The document is a summary report by the World Health Organization (WHO) Regional Office for the Eastern Mediterranean, focusing on a capacity-building workshop held in Abu Dhabi in 2019. The workshop addressed the management and care of substance use disorders, aiming to improve technical and manage...
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd...
The SAMHSA-HRSA Center for Integrated Health Solutions (CIHS) promotes the development of integrated primary and behavioral health services to better address the needs of individuals with mental health and substance use conditions, whether seen in specialty behavioral health or primary care provider...
